| Literature DB >> 22545065 |
Masaaki Tsujitani1, Yusuke Tanaka, Masato Sakon.
Abstract
We discuss a flexible method for modeling survival data using penalized smoothing splines when the values of covariates change for the duration of the study. The Cox proportional hazards model has been widely used for the analysis of treatment and prognostic effects with censored survival data. However, a number of theoretical problems with respect to the baseline survival function remain unsolved. We use the generalized additive models (GAMs) with B splines to estimate the survival function and select the optimum smoothing parameters based on a variant multifold cross-validation (CV) method. The methods are compared with the generalized cross-validation (GCV) method using data from a long-term study of patients with primary biliary cirrhosis (PBC).Entities:
Mesh:
Year: 2012 PMID: 22545065 PMCID: PMC3321736 DOI: 10.1155/2012/986176
Source DB: PubMed Journal: Comput Math Methods Med ISSN: 1748-670X Impact factor: 2.238
Values of covariates for deceased patient #9.
| Time interval | Midpoint day | Age (year) | Prothrombin time (sec) | Bilirubin (mg/dL) |
|
|---|---|---|---|---|---|
| 1 | 92.0 | 42.54 | 11.0 | 3.2 | 0 |
| 2 | 272.5 | 43.04 | 12.5 | 7.0 | 0 |
| 3 | 542.0 | 43.53 | 11.2 | 4.2 | 0 |
| 4 | 875.0 | 44.52 | 14.1 | 13.5 | 0 |
| 5 | 1211.5 | 45.35 | 11.5 | 12.0 | 0 |
| 6 | 1837.0 | 46.36 | 11.5 | 16.2 | 0 |
| 7 | 2339.0 | 48.78 | 13.0 | 14.8 | 1 |
Ranks and F values for nonparametric effects.
| No. | Model | Deviance | d.f. | CV (AIC) |
|---|---|---|---|---|
| I |
| 661.77 | 1933.16 | 691.99 (685.44) |
| II |
| 663.65 | 1934.57 | 690.54 (684.52) |
| III |
| 705.50 | 1933.93 | 739.03 (727.64) |
| IV | Age + | 663.65 | 1934.57 | 690.51 (684.51) |
| V | Age + | 686.63 | 1937.58 | 708.44 (701.46) |
| VI | Age + pro + | 675.80 | 1938.02 | 696.53 (689.77) |
Optimum smoothing parameters.
| Covariates | Variant | GCV |
|---|---|---|
| Time | 0.1 | 0.00045 |
| Age | 10 | 0.000015 |
| Prothrombin time | 0.001 | 0.00039 |
| Bilirubin | 0.001 | 0.00000017 |
Test of significance for the covariates (P values).
| Covariates | Variant | GCV |
|---|---|---|
| Time | 0.263 | 0.0028 |
| Age | <0.0001 | <0.0001 |
| Prothrombin time | <0.0001 | <0.0001 |
| Bilirubin | <0.0001 | <0.0001 |
Test of significance for spline effects.
| Spline effect | Δ | d.f. |
|---|---|---|
| Age | 0.0039 (Model IV-II) | 0.005 |
| Prothrombin time | 12.15 (Model VI-IV) | 3.45 |
| Bilirubin | 22.97 (Model V-IV) | 3.01 |
Figure 1Histogram of the bootstrapped Dev(b) for B = 400.
Figure 2Probability of survival over the next six months using the four models with respect to dead patient #9.
Figure 3Probability of survival over the next six months using the four models with respect to dead and censored data among all 312 patients.
Figure 4Box and whisker plots of probability of survival over the next six months using GAM with respect to dead data among all 312 patients.
Three types of “censored” and “liver transplantation.”
| Dead patient | Censored patient | Liver-transplanted patient | |||
|---|---|---|---|---|---|
|
| Liver transplant |
| Liver transplant |
| Liver transplant |
| 0 | 0 | 0 | 0 | 0 | 0 |
| . | . | . | . | . | . |
| . | . | . | . | . | . |
| 1 | 0 | 0 | 0 | 0 | 1 |
Values of covariates for dead patient #5.
| Time interval | Midpoint day | Age (year) | Prothrombin time (sec) | Bilirubin (mg/dL) | Liver trans-plantation |
|---|---|---|---|---|---|
| 1 | 99.5 | 38.11 | 10.9 | 3.4 | 0 |
| 2 | 295.0 | 38.65 | 10.7 | 1.9 | 0 |
| 3 | 580.0 | 39.18 | 10.5 | 2.5 | 0 |
| 4 | 933.5 | 40.21 | 11.4 | 5.7 | 0 |
| 5 | 1276.5 | 41.11 | 11.3 | 5.2 | 0 |
| 6 | 1480.0 | 42.09 | 13.9 | 19.0 | 1 |
Test of significance for covariates using model (19).
| Covariate |
|
|---|---|
| Age | <0.0001 |
| Prothrombin time | <0.0001 |
| Bilirubin | <0.0001 |
Deviance and d.f.
| Model | Deviance | d.f. |
|---|---|---|
| IV | 663.65 | 1934.57 |
| IV | 653.00 | 1934.00 |